Published within
|«
«
|
1
|
2
|
3
|
4
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
Overview of migraine, disorder definition, and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year prevalent case forecast, and key patient segments across the seven major markets.
Published By Datamonitor
|
21 Dec 2011 |
$5700
|
Report
|
In-depth analysis of key brands and pipeline agents indicated for the treatment of epilepsy. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.
Published By Datamonitor
|
20 Dec 2011 |
$11400
|
Report
|
In-depth analysis of key prescription brands and pipeline agents for the treatment of insomnia. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.
Published By Datamonitor
|
19 Dec 2011 |
$11400
|
Report
|
In depth analysis of key brands and pipeline agents indicated for the treatment of multiple sclerosis. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.
Published By Datamonitor
|
12 Dec 2011 |
$11400
|
Report
|
Qualitative and quantitative assessment of how biomarkers can change the diagnostic and commercial landscape in Alzheimer’s disease. The analysis provides an outline of the opportunities for drug and diagnostics companies in the Alzheimer’s market.
Published By Datamonitor
|
02 Dec 2011 |
$3800
|
Report
|
Assessment of the current and future multiple sclerosis market using a patient-based forecasting methodology. The analysis is designed to understand the future sales dynamics of marketed brands, key pipeline agents, and biosimilars.
Published By Datamonitor
|
01 Dec 2011 |
$11400
|
Report
|
Multiple Sclerosis: Pricing and Reimbursement provides an overview of pricing and reimbursement issues with disease-modifying drugs used to treat multiple sclerosis.
Published By Datamonitor
|
20 Oct 2011 |
$1900
|
Report
|
This report analyzes the potential impact of biosimilar multiple sclerosis therapies according to perceptions of US prescribers. The analysis is designed to provide an understanding of the biosimilar opportunities and implications to current players.
Published By Datamonitor
|
31 Aug 2011 |
$3800
|
Report
|
This report analyzes the unmet needs of multiple sclerosis treatment and the attributes of drugs that influence prescribing decisions. The analysis aims to understand the opportunities in the market and support the positioning of marketed brands.
Published By Datamonitor
|
09 Aug 2011 |
$5700
|
Report
|
This report examines the CNS market in China. It reviews the epidemiology and treatment of key conditions. It also provides analysis of the strengths, weaknesses, opportunities and threats of the market and strategies for market penetration.
Published By Datamonitor
|
05 Jul 2011 |
$5700
|
|«
«
|
1
|
2
|
3
|
4
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.